These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12883712)

  • 1. Expression of a 65 kDa oncofetal protein in human prostatic carcinoma.
    Hanausek M; Walaszek Z; King TM; Amos CI
    Oncol Rep; 2003; 10(5):1387-92. PubMed ID: 12883712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.
    Shalitin C; Epelbaum R; Moskovitz B; Segal R; Valansi C; Werner M; Livne PM
    Cancer Detect Prev; 1994; 18(5):357-65. PubMed ID: 7812982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
    Dehghani M; Mostafavi-Pour Z; Lotfi M; Shakeri S
    Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
    Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
    Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
    Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G
    Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of S100 protein from prostatic cancer patients using anti-S100 protein antibody immobilized on POS-PVA discs.
    Melo-Júnior MR; Filho JL; Cavalcanti CL; Patu VJ; Beltrão EI; Carvalho LB
    Biotechnol Bioeng; 2007 May; 97(1):182-7. PubMed ID: 17013937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA; Cohen RJ; Garrett KL
    BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer with a blood-based assay for early prostate cancer antigen.
    Paul B; Dhir R; Landsittel D; Hitchens MR; Getzenberg RH
    Cancer Res; 2005 May; 65(10):4097-100. PubMed ID: 15899799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer.
    Nagakawa O; Yamagishi T; Fujiuchi Y; Junicho A; Akashi T; Nagaike K; Fuse H
    Eur Urol; 2005 Oct; 48(4):686-90. PubMed ID: 16005141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
    deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
    Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
    Nam RK; Reeves JR; Toi A; Dulude H; Trachtenberg J; Emami M; Daigneault L; Panchal C; Sugar L; Jewett MA; Narod SA
    J Urol; 2006 Apr; 175(4):1291-7. PubMed ID: 16515983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined assay of serum prostate specific antigen and chromogranin A helps diagnosis of prostate cancer].
    Sun CC; Zheng W; Kong CZ; Wang X; Yang CM
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):904-5, 909. PubMed ID: 17121020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
    Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study of the prostate-specific antigen in prostatic cancer].
    Karseladze AI; Rytin IIe; Budunova IV
    Arkh Patol; 2004; 66(2):3-7. PubMed ID: 15154373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.